Pharmacovigilance Market 2019-2023: Global Leaders: ACCELRYS, CERTARA, CHEMICAL COMPUTING GROUP, COMPUGEN LTD, ENTELOS, GENEDATA AG, INSILICO BIOTECHNOLOGY AG

According to WHO, pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The focus of pharmacovigilance is on ADR (adverse drug reactions) and drug toxicity. Increasing number of adverse drug reactions (ADRs) imposes a significant burden on the healthcare system by extending patient morbidity under chronic condition. The global pharmacovigilance market is expected to register a CAGR of 12.8% during the forecast period, 2018 to 2023.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16762
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Lack of Skilled Labor
The process of pharmacovigilance requires the use of skilled professionals to manage adverse events and clinical-trial activities, and contribute to ensure compliance of pharmacovigilance activities. However, the dearth of skilled professionals in the market is restraining its growth,
Additionally, high risk associated with data security is also restraining the market growth.

Major players:
ACCENTURE, CLINQUEST GROUP B.V., COGNIZANT, LABORATORY CORPORATION OF AMERICA HOLDINGS, IBM CORPORATION, ARISGLOBAL, ICON PLC, CAPGEMINI, ITCLINICAL, IMEDGLOBAL, FORESIGHT GROUP INTERNATIONAL AG, TAKE SOLUTIONS LTD., PAREXEL INTERNATIONAL CORPORATION, BIOCLINICA WIPRO LTD., UNITED BIOSOURCE CORPORATION amongst others.

Key Developments in the Market
February 2017: PAREXEL announces definitive agreement to acquire the medical affairs company
June 2017: Accenture has been named a leader in IDC MarketScape on Life Science Drug Safety Services.

Request Discount on this report @ https://marketprognosis.com/discount-request/16762
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Growing Incidence Rates of ADR and Drug Toxicity
The ADR or adverse drug reaction is defined as an injury caused by taking a medication. Adverse drug reactions (ADR) are far more common than one would think. It is estimated that ADR is one of the leading causes of deaths, right after heart disease, cancer, and stroke, globally. Further, it is estimated that ADRs are the sixth leading cause of death worldwide. With the increase in number of adverse drug reactions (ADRs), there has been a significant burden on the healthcare system. The need to reduce the burden of ADRs has led to an increase in the demand for pharmacovigilance services, thus expanding the global market size.
Other factors driving the market growth are increasing drug consumption and drug development rates and increasing trend of outsourcing pharmacovigilance services.

North America to Dominate the Market
North America dominates the market due to rising mortality rates, adverse drug events, and growing patient concerns for safety and efficacy of drugs.

Enquiry Before Buying@ https://marketprognosis.com/enquiry/16762
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.